Transcatheter Heart Valve Replacement Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of Transcatheter Heart Valve Replacement Market
The global Transcatheter Heart Valve Replacement (THVR) market is experiencing significant growth, driven by advancements in minimally invasive procedures and an increasing prevalence of heart valve diseases. According to a report by Acumen Research and Consulting, the THVR market was valued at USD 5.1 billion in 2022 and is projected to reach USD 14.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.4% .
Market Dynamics
1. Rising Prevalence of Cardiovascular Diseases
The aging global population and the increasing incidence of cardiovascular diseases are major factors contributing to the growth of the THVR market. Conditions such as aortic stenosis and mitral regurgitation are becoming more prevalent, leading to a higher demand for valve replacement procedures. Transcatheter procedures offer a less invasive alternative to traditional open-heart surgery, making them an attractive option for patients and healthcare providers alike.
2. Technological Advancements
Innovations in valve design and delivery systems have significantly improved the safety and efficacy of THVR procedures. The development of balloon-expandable and self-expanding valves has enhanced procedural success rates and patient outcomes. Additionally, advancements in imaging techniques have facilitated more precise valve placement, further reducing complications and recovery times.
3. Minimally Invasive Nature
The less invasive approach of THVR procedures results in shorter hospital stays, quicker recovery times, and reduced risk of complications compared to traditional surgery. These benefits are particularly appealing to elderly patients and those with multiple comorbidities, driving the adoption of THVR procedures worldwide.
Market Segmentation
1. By Product Type
Transcatheter Aortic Valve Replacement (TAVR): TAVR is the dominant segment in the THVR market, accounting for a significant share due to its widespread adoption and proven efficacy in treating aortic stenosis.
Transcatheter Mitral Valve Replacement (TMVR): TMVR is an emerging segment, with ongoing research and development efforts aimed at addressing the unmet needs in treating mitral valve diseases.
Transcatheter Pulmonary Valve Replacement (TPVR): TPVR is a niche segment, primarily used in pediatric patients with congenital heart defects.
2. By End User
Hospitals: Hospitals are the primary end-users of THVR procedures, owing to their advanced infrastructure and specialized medical staff.
Specialty Clinics: Specialty clinics are emerging as significant contributors to the THVR market, providing focused care and treatment options for patients.
Regional Insights
North America holds a substantial share of the THVR market, driven by advanced healthcare infrastructure, high patient awareness, and favorable reimbursement policies. The United States, in particular, leads in the adoption of THVR procedures, with a significant number of procedures performed annually.
The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, attributed to the increasing prevalence of cardiovascular diseases, improving healthcare infrastructure, and rising patient awareness. Countries like China and India are emerging as key markets for THVR procedures, with a growing number of healthcare facilities offering these services.
Competitive Landscape
The THVR market is characterized by the presence of several key players, including:
Edwards Lifesciences Corporation: A global leader in heart valve replacement technologies, Edwards Lifesciences offers a range of transcatheter heart valves and related products.
Medtronic plc: Medtronic provides a comprehensive portfolio of cardiovascular solutions, including transcatheter heart valve replacement devices.
Abbott Laboratories: Abbott offers a range of medical devices, including those for heart valve replacement procedures.
Boston Scientific Corporation: Boston Scientific develops and manufactures a variety of medical devices, including those for transcatheter heart valve replacement.
LivaNova PLC: LivaNova specializes in medical technologies, including heart valve replacement solutions.
These companies are focusing on strategic initiatives such as product innovation, mergers and acquisitions, and partnerships to strengthen their market position and expand their product offerings.
Future Outlook
The THVR market is poised for continued growth, driven by technological advancements, increasing patient demand for minimally invasive procedures, and expanding indications for valve replacement therapies. Ongoing research and development efforts aim to address the challenges associated with treating mitral and pulmonary valve diseases, further broadening the scope of THVR procedures.
In conclusion, the Transcatheter Heart Valve Replacement market is set to experience significant growth in the coming years, offering promising opportunities for healthcare providers, patients, and industry stakeholders. The shift towards minimally invasive procedures and continuous innovations in valve technologies are expected to shape the future of heart valve replacement therapies.
ATTRIBUTE DETAILS
Study Period 2015-2026
Base Year 2018
Forecast Period 2019-2026
Historical Period 2015-2017
Unit Value (USD billion)
Segmentation By Product Type
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Valve Replacement (TMVR)
Transcatheter Pulmonary Valve Replacement(TPVR)
By End User
Hospitals
Specialty Clinics & Others
By Geography
North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and the Rest of Latin America)
Middle East& Africa (South Africa, GCC and the Rest of Middle East & Africa)
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
The global Transcatheter Heart Valve Replacement (THVR) market is experiencing significant growth, driven by advancements in minimally invasive procedures and an increasing prevalence of heart valve diseases. According to a report by Acumen Research and Consulting, the THVR market was valued at USD 5.1 billion in 2022 and is projected to reach USD 14.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.4% .
Market Dynamics
1. Rising Prevalence of Cardiovascular Diseases
The aging global population and the increasing incidence of cardiovascular diseases are major factors contributing to the growth of the THVR market. Conditions such as aortic stenosis and mitral regurgitation are becoming more prevalent, leading to a higher demand for valve replacement procedures. Transcatheter procedures offer a less invasive alternative to traditional open-heart surgery, making them an attractive option for patients and healthcare providers alike.
2. Technological Advancements
Innovations in valve design and delivery systems have significantly improved the safety and efficacy of THVR procedures. The development of balloon-expandable and self-expanding valves has enhanced procedural success rates and patient outcomes. Additionally, advancements in imaging techniques have facilitated more precise valve placement, further reducing complications and recovery times.
3. Minimally Invasive Nature
The less invasive approach of THVR procedures results in shorter hospital stays, quicker recovery times, and reduced risk of complications compared to traditional surgery. These benefits are particularly appealing to elderly patients and those with multiple comorbidities, driving the adoption of THVR procedures worldwide.
Market Segmentation
1. By Product Type
Transcatheter Aortic Valve Replacement (TAVR): TAVR is the dominant segment in the THVR market, accounting for a significant share due to its widespread adoption and proven efficacy in treating aortic stenosis.
Transcatheter Mitral Valve Replacement (TMVR): TMVR is an emerging segment, with ongoing research and development efforts aimed at addressing the unmet needs in treating mitral valve diseases.
Transcatheter Pulmonary Valve Replacement (TPVR): TPVR is a niche segment, primarily used in pediatric patients with congenital heart defects.
2. By End User
Hospitals: Hospitals are the primary end-users of THVR procedures, owing to their advanced infrastructure and specialized medical staff.
Specialty Clinics: Specialty clinics are emerging as significant contributors to the THVR market, providing focused care and treatment options for patients.
Regional Insights
North America holds a substantial share of the THVR market, driven by advanced healthcare infrastructure, high patient awareness, and favorable reimbursement policies. The United States, in particular, leads in the adoption of THVR procedures, with a significant number of procedures performed annually.
The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, attributed to the increasing prevalence of cardiovascular diseases, improving healthcare infrastructure, and rising patient awareness. Countries like China and India are emerging as key markets for THVR procedures, with a growing number of healthcare facilities offering these services.
Competitive Landscape
The THVR market is characterized by the presence of several key players, including:
Edwards Lifesciences Corporation: A global leader in heart valve replacement technologies, Edwards Lifesciences offers a range of transcatheter heart valves and related products.
Medtronic plc: Medtronic provides a comprehensive portfolio of cardiovascular solutions, including transcatheter heart valve replacement devices.
Abbott Laboratories: Abbott offers a range of medical devices, including those for heart valve replacement procedures.
Boston Scientific Corporation: Boston Scientific develops and manufactures a variety of medical devices, including those for transcatheter heart valve replacement.
LivaNova PLC: LivaNova specializes in medical technologies, including heart valve replacement solutions.
These companies are focusing on strategic initiatives such as product innovation, mergers and acquisitions, and partnerships to strengthen their market position and expand their product offerings.
Future Outlook
The THVR market is poised for continued growth, driven by technological advancements, increasing patient demand for minimally invasive procedures, and expanding indications for valve replacement therapies. Ongoing research and development efforts aim to address the challenges associated with treating mitral and pulmonary valve diseases, further broadening the scope of THVR procedures.
In conclusion, the Transcatheter Heart Valve Replacement market is set to experience significant growth in the coming years, offering promising opportunities for healthcare providers, patients, and industry stakeholders. The shift towards minimally invasive procedures and continuous innovations in valve technologies are expected to shape the future of heart valve replacement therapies.
ATTRIBUTE DETAILS
Study Period 2015-2026
Base Year 2018
Forecast Period 2019-2026
Historical Period 2015-2017
Unit Value (USD billion)
Segmentation By Product Type
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Valve Replacement (TMVR)
Transcatheter Pulmonary Valve Replacement(TPVR)
By End User
Hospitals
Specialty Clinics & Others
By Geography
North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and the Rest of Latin America)
Middle East& Africa (South Africa, GCC and the Rest of Middle East & Africa)
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
115 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Cardiovascular Disorders – For Key Countries
- 4.2. Key Industry Trends
- 4.3. Technological Advancement
- 4.4. New Product Launches
- 4.5. Key Industry Developments - Mergers, Acquisitions and Partnerships
- 5. Global Transcatheter Heart Valve Replacement (THVR) Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product Type
- 5.2.1. Transcatheter Aortic Valve Replacement (TAVR)
- 5.2.2. Transcatheter Mitral Valve Replacement (TMVR)
- 5.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Hospitals
- 5.3.2. Specialty Clinics & Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Transcatheter Heart Valve Replacement (THVR) Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product Type
- 6.2.1. Transcatheter Aortic Valve Replacement (TAVR)
- 6.2.2. Transcatheter Mitral Valve Replacement (TMVR)
- 6.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Hospitals
- 6.3.2. Specialty Clinics & Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Transcatheter Heart Valve Replacement (THVR) Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product Type
- 7.2.1. Transcatheter Aortic Valve Replacement (TAVR)
- 7.2.2. Transcatheter Mitral Valve Replacement (TMVR)
- 7.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics & Others
- 7.4. Market Analysis, Insights and Forecast – By Countries/ Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Transcatheter Heart Valve Replacement (THVR) Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product Type
- 8.2.1. Transcatheter Aortic Valve Replacement (TAVR)
- 8.2.2. Transcatheter Mitral Valve Replacement (TMVR)
- 8.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics & Others
- 8.4. Market Analysis, Insights and Forecast – By Countries/ Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Transcatheter Heart Valve Replacement (THVR) Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product Type
- 9.2.1. Transcatheter Aortic Valve Replacement (TAVR)
- 9.2.2. Transcatheter Mitral Valve Replacement (TMVR)
- 9.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics & Others
- 9.4. Market Analysis, Insights and Forecast – By Countries/ Sub regions
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Transcatheter Heart Valve Replacement (THVR) Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product Type
- 10.2.1. Transcatheter Aortic Valve Replacement (TAVR)
- 10.2.2. Transcatheter Mitral Valve Replacement (TMVR)
- 10.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
- 10.3. Market Analysis, Insights and Forecast – By End User
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics & Others
- 10.4. Market Analysis, Insights and Forecast – By Countries/ Sub region
- 10.4.1. South Africa
- 10.4.2. GCC
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Company Profiles (Overview, Product Types & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.3.1. Edwards Lifesciences Corporation
- 11.3.1.1. Overview,
- 11.3.1.2. Product Types & Services,
- 11.3.1.3. SWOT analysis,
- 11.3.1.4. Recent developments,
- 11.3.1.5. strategies,
- 11.3.1.6. financials (based on availability)
- 11.3.2. Abbott
- 11.3.2.1. Overview,
- 11.3.2.2. Product Types & Services,
- 11.3.2.3. SWOT analysis,
- 11.3.2.4. Recent developments,
- 11.3.2.5. strategies,
- 11.3.2.6. financials (based on availability)
- 11.3.3. Medtronic
- 11.3.3.1. Overview,
- 11.3.3.2. Product Types & Services,
- 11.3.3.3. SWOT analysis,
- 11.3.3.4. Recent developments,
- 11.3.3.5. strategies,
- 11.3.3.6. financials (based on availability)
- 11.3.4. LivaNova PLC
- 11.3.4.1. Overview,
- 11.3.4.2. Product Types & Services,
- 11.3.4.3. SWOT analysis,
- 11.3.4.4. Recent developments,
- 11.3.4.5. strategies,
- 11.3.4.6. financials (based on availability)
- 11.3.5. Boston Scientific Corporation
- 11.3.5.1. Overview,
- 11.3.5.2. Product Types & Services,
- 11.3.5.3. SWOT analysis,
- 11.3.5.4. Recent developments,
- 11.3.5.5. strategies,
- 11.3.5.6. financials (based on availability)
- 11.3.6. CryoLife, Inc.
- 11.3.6.1. Overview,
- 11.3.6.2. Product Types & Services,
- 11.3.6.3. SWOT analysis,
- 11.3.6.4. Recent developments,
- 11.3.6.5. strategies,
- 11.3.6.6. financials (based on availability)
- 11.3.7. Micro Interventional Devices, Inc.
- 11.3.7.1. Overview,
- 11.3.7.2. Product Types & Services,
- 11.3.7.3. SWOT analysis,
- 11.3.7.4. Recent developments,
- 11.3.7.5. strategies,
- 11.3.7.6. financials (based on availability)
- 11.3.8. Other Prominenet Players
- 11.3.8.1. Overview,
- 11.3.8.2. Product Types & Services,
- 11.3.8.3. SWOT analysis,
- 11.3.8.4. Recent developments,
- 11.3.8.5. strategies,
- 11.3.8.6. financials (based on availability)
- 12. Strategic Recommendations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
